DrugPipeline.net has announced the addition of “Global Atopic Dermatitis Drugs Market 2017-2021” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 03/22/2017 --Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever), and chronic dermatitis. In this condition, the skin becomes extremely itchy and inflamed, which causes redness, cracking, weeping, swelling, vesicle formation, crushing, and scaling. Atopic dermatitis is very common worldwide, and its prevalence rate is increasing. The data estimates suggest that nearly 60% of the patients develop symptoms in the first year of life, and 88%-92% develop symptoms before the age of five.

Report forecast the global atopic dermatitis drugs market to grow at a CAGR of 4.20% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global atopic dermatitis drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of atopic dermatitis drugs.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Atopic Dermatitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- LEO Pharma
- Mylan
- Valeant
- Bayer HealthCare
- Encore Dermatology

Market driver
- Growing prevalence of food allergies exacerbating atopic dermatitis
- For a full, detailed list, view our report

Market challenge
- Poor patient adherence due to inadequate information on drug usage
- For a full, detailed list, view our report

Market trend
- Increasing M&A leading to market consolidation
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 68 pages "Global Connected Breath Analyzer Devices Market 2017-2021" report covers Executive summary, Scope of the report, Market research methodology, Introduction, An overview of atopic dermatitis, Pipeline analysis, Market landscape, Five force analysis, Market segment by ROA, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-atopic-dermatitis-drugs-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.